Ben Halladay

CFO at Esperion Therapeutics

Ben has been their Chief Financial Officer since 2022. He was promoted to the CFO role after serving several years as Esperion’s Senior Director, Financial Planning and Analysis where he oversaw the financial planning and analytics team and partnered with executive leadership and the commercial organization to help the company manage its financial goals. Prior to joining Esperion, Ben held financial and business roles of increasing responsibility with National Oilwell Varco, BMC Software, and Pfizer.

Ben holds a Bachelor of Arts in History from Syracuse University and a Master in Business Administration from Fordham’s Gabelli School of Business.

Links

Previous companies

BMC Software logo
Pfizer logo

Timeline

  • CFO

    Current role

View in org chart